Bausch + Lomb Says FDA Supportive In Principle Of Initial Study Design For Oral Dry AMD Drug BL1243, Expects 2027 Start

뉴스 본문을 불러오고 있어요.

Bausch + Lomb Says FDA Supportive In Principle Of Initial Study Design For Oral Dry AMD Drug BL1243, Expects 2027 Start | 웨이프 WAPE

기사 요약